Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 416

1.

Probability of Soluble Tissue Factor Release Lead to the Elevation of D-dimer as a Biomarker for Traumatic Brain Injury.

Suehiro E, Fujiyama Y, Kiyohira M, Motoki Y, Nojima J, Suzuki M.

Neurol Med Chir (Tokyo). 2019 Jan 23. doi: 10.2176/nmc.oa.2018-0254. [Epub ahead of print]

2.

Methylated promoter DNA of CDO1 gene and preoperative serum CA19-9 are prognostic biomarkers in primary extrahepatic cholangiocarcinoma.

Nakamoto S, Kumamoto Y, Igarashi K, Fujiyama Y, Nishizawa N, Ei S, Tajima H, Kaizu T, Watanabe M, Yamashita K.

PLoS One. 2018 Oct 16;13(10):e0205864. doi: 10.1371/journal.pone.0205864. eCollection 2018.

3.

Chylous ascites, anti-interferon-gamma autoantibody, and angioimmunoblastic T-cell lymphoma: a rare but intriguing connection over Mycobacterium avium.

Koizumi Y, Sakagami T, Minamiguchi H, Makino A, Aoki A, Hodohara K, Mikamo H, Andoh A, Fujiyama Y.

Med Microbiol Immunol. 2019 Feb;208(1):33-37. doi: 10.1007/s00430-018-0555-0. Epub 2018 Aug 6.

PMID:
30083859
4.

Randomized, double-blind, placebo-controlled study vs data in the daily practice using linaclotide in patients with irritable bowel syndrome with constipation.

Fukudo S, Nakajima A, Fujiyama Y, Kosako M, Nakagawa A, Akiho H, Nakashima Y, Johnston JM, Miwa H.

Neurogastroenterol Motil. 2018 May;30(5):e13363. doi: 10.1111/nmo.13363. No abstract available.

PMID:
29700962
5.

Determining an optimal dose of linaclotide for use in Japanese patients with irritable bowel syndrome with constipation: A phase II randomized, double-blind, placebo-controlled study.

Fukudo S, Nakajima A, Fujiyama Y, Kosako M, Nakagawa A, Akiho H, Nakashima Y, Johnston JM, Miwa H.

Neurogastroenterol Motil. 2018 May;30(5):e13275. doi: 10.1111/nmo.13275. Epub 2017 Dec 26.

PMID:
29278278
6.

D-Dimer Elevation as a Blood Biomarker for Detection of Structural Disorder in Mild Traumatic Brain Injury.

Sugimoto K, Suehiro E, Shinoyama M, Sadahiro H, Haji K, Fujiyama Y, Kawano R, Nishioka M, Suzuki M.

J Neurotrauma. 2017 Dec 1;34(23):3245-3248. doi: 10.1089/neu.2017.5240. Epub 2017 Oct 27.

PMID:
28895444
7.

Association between income inequality and dental status in Japanese older adults: Analysis of data from JAGES2013.

Tashiro A, Aida J, Shobugawa Y, Fujiyama Y, Yamamoto T, Saito R, Kondo K.

Nihon Koshu Eisei Zasshi. 2017;64(4):190-196. doi: 10.11236/jph.64.4_190. Japanese.

8.

Directions for use of intracranial pressure monitoring in treatment of severe traumatic brain injury using data from the Japan Neurotrauma Data Bank.

Suehiro E M D Ph D, Fujiyama Y, Koizumi H, Suzuki M.

J Neurotrauma. 2017 Mar 23. doi: 10.1089/neu.2016.4948. [Epub ahead of print]

PMID:
28335668
9.

Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients.

Koizumi Y, Shimizu K, Shigeta M, Okuno T, Minamiguchi H, Kito K, Hodohara K, Yamagishi Y, Andoh A, Fujiyama Y, Mikamo H.

BMC Infect Dis. 2017 Jan 5;17(1):27. doi: 10.1186/s12879-016-2116-8.

10.

Two cases of cystic artery pseudoaneurysm rupture due to acute cholecystitis with gallstone impaction in the neck.

Kaida S, Arahata K, Itou A, Takarabe S, Kimura K, Kishikawa H, Nishida J, Fujiyama Y, Takigawa Y, Matsui J.

Nihon Shokakibyo Gakkai Zasshi. 2016 Sep;113(9):1572-81. doi: 10.11405/nisshoshi.113.1572. Review. Japanese.

PMID:
27593367
11.

Decreased Flow Velocity with Transcranial Color-Coded Duplex Sonography Correlates with Delayed Cerebral Ischemia due to Peripheral Vasospasm of the Middle Cerebral Artery.

Sadahiro H, Shirao S, Yoneda H, Ishihara H, Oku T, Inamura A, Yamane A, Sugimoto K, Fujiyama Y, Suzuki M.

J Stroke Cerebrovasc Dis. 2016 Oct;25(10):2352-9. doi: 10.1016/j.jstrokecerebrovasdis.2016.05.032. Epub 2016 Aug 17.

PMID:
27544866
12.

Effects of Brain Temperature on Cerebrovascular Autoregulation During the Acute Stage of Severe Traumatic Brain Injury.

Koizumi H, Suehiro E, Fujiyama Y, Yoneda H, Ishihara H, Nomura S, Fujii M, Suzuki M.

Acta Neurochir Suppl. 2016;122:193-7. doi: 10.1007/978-3-319-22533-3_39.

PMID:
27165905
13.

Importance of Early Postoperative Body Temperature Management for Treatment of Subarachnoid Hemorrhage.

Suehiro E, Sadahiro H, Goto H, Oku T, Oka F, Fujiyama Y, Shirao S, Yoneda H, Koizumi H, Ishihara H, Suzuki M.

J Stroke Cerebrovasc Dis. 2016 Jun;25(6):1482-8. doi: 10.1016/j.jstrokecerebrovasdis.2016.01.053. Epub 2016 Mar 25.

PMID:
27020121
14.

A case of gastric adenocarcinoma of fundic gland type resected by combination of laparoscopic and endoscopic approaches to neoplasia with non-exposure technique (CLEAN-NET).

Kato M, Uraoka T, Isobe Y, Abe K, Hirata T, Takada Y, Wada M, Takatori Y, Takabayashi K, Fujiyama Y, Sekiya K, Kawaguchi Y, Sukeda A, Shiraishi J.

Clin J Gastroenterol. 2015 Dec;8(6):393-9. doi: 10.1007/s12328-015-0619-2. Epub 2015 Nov 28.

PMID:
26615600
15.

A case of extramedullary involvement of acute monocytic leukemia that presented as obstructive jaundice.

Takatori Y, Kato M, Sakaguchi E, Banno S, Abe K, Takada Y, Hirata T, Wada M, Kinoshita S, Takabayashi K, Kikuchi M, Kikuchi M, Fujiyama Y, Uraoka T.

Gastrointest Endosc. 2016 Mar;83(3):666-7; discussion 667. doi: 10.1016/j.gie.2015.09.026. Epub 2015 Sep 28. No abstract available.

PMID:
26422978
16.

Evaluation of Kampo medicine in the clinical practice guideline for irritable bowel syndrome.

Fukudo S, Kaneko H, Akiho H, Inamori M, Endo Y, Okumura T, Kanazawa M, Kamiya T, Sato K, Chiba T, Furuta K, Yamato S, Arakawa T, Fujiyama Y, Azuma T, Fujimoto K, Mine T, Miura S, Kinoshita Y, Watanabe M, Sugano K, Shimosegawa T.

J Gastroenterol. 2015 Jul;50(7):817-8. doi: 10.1007/s00535-015-1074-z. Epub 2015 Jun 23. No abstract available.

PMID:
26100007
17.

Real-time ultrasound-guided endoscopic surgery for putaminal hemorrhage.

Sadahiro H, Nomura S, Goto H, Sugimoto K, Inamura A, Fujiyama Y, Yamane A, Oku T, Shinoyama M, Suzuki M.

J Neurosurg. 2015 Nov;123(5):1151-5. doi: 10.3171/2014.11.JNS141508. Epub 2015 Jun 5.

PMID:
26047414
18.

Evidence-based clinical practice guidelines for irritable bowel syndrome.

Fukudo S, Kaneko H, Akiho H, Inamori M, Endo Y, Okumura T, Kanazawa M, Kamiya T, Sato K, Chiba T, Furuta K, Yamato S, Arakawa T, Fujiyama Y, Azuma T, Fujimoto K, Mine T, Miura S, Kinoshita Y, Sugano K, Shimosegawa T.

J Gastroenterol. 2015 Jan;50(1):11-30. doi: 10.1007/s00535-014-1017-0. Epub 2014 Dec 12.

PMID:
25500976
19.

Predictors of deterioration indicating a requirement for surgery in mild to moderate traumatic brain injury.

Suehiro E, Koizumi H, Fujiyama Y, Yoneda H, Suzuki M.

Clin Neurol Neurosurg. 2014 Dec;127:97-100. doi: 10.1016/j.clineuro.2014.10.007. Epub 2014 Oct 22.

PMID:
25459251
20.

Recent advances and future directions of hypothermia therapy for traumatic brain injury.

Suehiro E, Koizumi H, Fujiyama Y, Suzuki M.

Neurol Med Chir (Tokyo). 2014;54(11):863-9. Epub 2014 Oct 31.

21.

Update on intensive neuromonitoring for patients with traumatic brain injury: a review of the literature and the current situation.

Koizumi H, Suehiro E, Fujiyama Y, Sugimoto K, Inoue T, Suzuki M.

Neurol Med Chir (Tokyo). 2014;54(11):870-7. Epub 2014 Oct 31. Review.

22.

[Two cases of successful sorafenib retreatment with the addition of steroid therapy following sorafenib-induced erythema multiforme in two patients with hepatocellular carcinoma].

Shioya M, Nishimura T, Nishida A, Inatomi O, Bamba S, Sasaki M, Andoh A, Fujiyama Y.

Nihon Shokakibyo Gakkai Zasshi. 2014 Jul;111(7):1424-32. Japanese.

PMID:
24998734
23.

Brain abscess associated with patent foramen ovale.

Sadahiro H, Nomura S, Inamura A, Yamane A, Sugimoto K, Fujiyama Y, Suzuki M.

Acta Neurochir (Wien). 2014 Oct;156(10):1971-6; discussion 1976. doi: 10.1007/s00701-014-2170-1. Epub 2014 Jul 1.

PMID:
24975278
24.

Predicting Mucosal Healing in Crohn's Disease Using Practical Clinical Indices with Regard to the Location of Active Disease.

Bamba S, Tsujikawa T, Ban H, Imaeda H, Inatomi O, Nishida A, Sasaki M, Andoh A, Fujiyama Y.

Hepatogastroenterology. 2014 May;61(131):689-96.

PMID:
26176058
25.

Characterization of gut microbiota profiles by disease activity in patients with Crohn's disease using data mining analysis of terminal restriction fragment length polymorphisms.

Andoh A, Kobayashi T, Kuzuoka H, Tsujikawa T, Suzuki Y, Hirai F, Matsui T, Nakamura S, Matsumoto T, Fujiyama Y.

Biomed Rep. 2014 May;2(3):370-373. Epub 2014 Mar 14.

26.

Data mining analysis of terminal restriction fragment length polymorphism shows geographical differences in the human gut microbiota.

Andoh A, Kobayashi T, Kuzuoka H, Suzuki Y, Matsui T, Nakamura S, Matsumoto T, Fujiyama Y, Bamba T.

Biomed Rep. 2013 Jul;1(4):559-562. Epub 2013 May 30.

27.

An exquisitely preserved troodontid theropod with new information on the palatal structure from the Upper Cretaceous of Mongolia.

Tsuihiji T, Barsbold R, Watabe M, Tsogtbaatar K, Chinzorig T, Fujiyama Y, Suzuki S.

Naturwissenschaften. 2014 Feb;101(2):131-42. doi: 10.1007/s00114-014-1143-9. Epub 2014 Jan 19.

PMID:
24441791
28.

Mannan-binding protein, a C-type serum lectin, recognizes primary colorectal carcinomas through tumor-associated Lewis glycans.

Nonaka M, Imaeda H, Matsumoto S, Yong Ma B, Kawasaki N, Mekata E, Andoh A, Saito Y, Tani T, Fujiyama Y, Kawasaki T.

J Immunol. 2014 Feb 1;192(3):1294-301. doi: 10.4049/jimmunol.1203023. Epub 2014 Jan 3.

29.

Cell division cycle-associated protein 1 overexpression is essential for the malignant potential of colorectal cancers.

Kobayashi Y, Takano A, Miyagi Y, Tsuchiya E, Sonoda H, Shimizu T, Okabe H, Tani T, Fujiyama Y, Daigo Y.

Int J Oncol. 2014 Jan;44(1):69-77. doi: 10.3892/ijo.2013.2177. Epub 2013 Nov 15.

PMID:
24247253
30.

Afferent loop syndrome successfully treated by endoscopic ultrasound-guided transgastric drainage.

Bamba S, Shiomi H, Fujiyama Y.

Dig Endosc. 2013 Nov;25(6):632-3. doi: 10.1111/den.12168. Epub 2013 Sep 30. No abstract available.

PMID:
24112370
31.

Changes of energy metabolism, nutritional status and serum cytokine levels in patients with Crohn's disease after anti-tumor necrosis factor-α therapy.

Nishida N, Sasaki M, Kurihara M, Ichimaru S, Wakita M, Bamba S, Andoh A, Fujiyama Y, Amagai T.

J Clin Biochem Nutr. 2013 Sep;53(2):122-7. doi: 10.3164/jcbn.13-18. Epub 2013 Aug 31.

32.

Precursor-derived versus de-novo carcinogenesis depends on lineage-specific mucin phenotypes of intramucosal gland-forming gastric neoplasms.

Nishimura R, Mukaisho K, Yamamoto H, Sonoda A, Andoh A, Fujiyama Y, Hattori T, Sugihara H.

Histopathology. 2013 Nov;63(5):616-29. doi: 10.1111/his.12208. Epub 2013 Aug 19.

PMID:
24033890
33.

Refractory mucous membrane pemphigoid which developed after allogeneic stem cell transplantation and was successfully treated with rituximab.

Nishimura R, Fujimoto N, Kito K, Uchiyama K, Koga H, Hodohara K, Hashimoto T, Fujiyama Y, Tanaka T.

Eur J Dermatol. 2013 Jul-Aug;23(4):562-4. doi: 10.1684/ejd.2013.2090. No abstract available.

PMID:
24001878
34.

Genetic lineages of undifferentiated-type gastric carcinomas analysed by unsupervised clustering of genomic DNA microarray data.

Sonoda A, Mukaisho K, Nakayama T, Diem VT, Hattori T, Andoh A, Fujiyama Y, Sugihara H.

BMC Med Genomics. 2013 Jul 19;6:25. doi: 10.1186/1755-8794-6-25.

35.

[A case of metastatic colon cancer effectively treated by XELOX and IRIS].

Nishizawa T, Kinoshita S, Sakuno T, Fujiyama Y, Kikuchi M, Kaneko H, Suzuki H, Takahashi M.

Gan To Kagaku Ryoho. 2013 Jun;40(6):807-9. Japanese.

PMID:
23863664
36.

Pharmacokinetic interaction between sorafenib and prednisolone in a patient with hepatocellular carcinoma.

Noda S, Shioya M, Hira D, Fujiyama Y, Morita SY, Terada T.

Cancer Chemother Pharmacol. 2013 Jul;72(1):269-72. doi: 10.1007/s00280-013-2187-9. Epub 2013 May 15.

PMID:
23673446
37.

Relationship between serum infliximab trough levels and endoscopic activities in patients with Crohn's disease under scheduled maintenance treatment.

Imaeda H, Bamba S, Takahashi K, Fujimoto T, Ban H, Tsujikawa T, Sasaki M, Fujiyama Y, Andoh A.

J Gastroenterol. 2014 Apr;49(4):674-82. doi: 10.1007/s00535-013-0829-7. Epub 2013 May 11.

PMID:
23666424
38.

Regulation of eotaxin-3/CC chemokine ligand 26 expression by T helper type 2 cytokines in human colonic myofibroblasts.

Takahashi K, Imaeda H, Fujimoto T, Ban H, Bamba S, Tsujikawa T, Sasaki M, Fujiyama Y, Andoh A.

Clin Exp Immunol. 2013 Aug;173(2):323-31. doi: 10.1111/cei.12117.

39.

Epithelial expression of interleukin-37b in inflammatory bowel disease.

Imaeda H, Takahashi K, Fujimoto T, Kasumi E, Ban H, Bamba S, Sonoda H, Shimizu T, Fujiyama Y, Andoh A.

Clin Exp Immunol. 2013 Jun;172(3):410-6. doi: 10.1111/cei.12061.

40.

Clinical utility of newly developed immunoassays for serum concentrations of adalimumab and anti-adalimumab antibodies in patients with Crohn's disease.

Imaeda H, Takahashi K, Fujimoto T, Bamba S, Tsujikawa T, Sasaki M, Fujiyama Y, Andoh A.

J Gastroenterol. 2014 Jan;49(1):100-9. doi: 10.1007/s00535-013-0803-4. Epub 2013 Apr 11.

PMID:
23575576
41.

Threaded biliary inside stents are a safe and effective therapeutic option in cases of malignant hilar obstruction.

Inatomi O, Bamba S, Shioya M, Mochizuki Y, Ban H, Tsujikawa T, Saito Y, Andoh A, Fujiyama Y.

BMC Gastroenterol. 2013 Feb 14;13:31. doi: 10.1186/1471-230X-13-31.

42.

[A case report: feasible treatment of adalimumab for Crohn disease during pregnancy].

Tsujikawa T, Sakai S, Fujii M, Saotome T, Imaeda H, Bamba S, Andoh A, Fujiyama Y.

Nihon Shokakibyo Gakkai Zasshi. 2013 Feb;110(2):243-7. Japanese.

PMID:
23381212
43.

Multicenter prospective study for clinical and endoscopic efficacies of leukocytapheresis therapy in patients with ulcerative colitis.

Okuyama Y, Andoh A, Nishishita M, Fukunaga K, Kamikozuru K, Yokoyama Y, Ueno Y, Tanaka S, Kuge H, Yoshikawa S, Sugahara A, Anami E, Munetomo Y, Watanabe C, Fujiyama Y, Matsumoto T.

Scand J Gastroenterol. 2013 Apr;48(4):412-8. doi: 10.3109/00365521.2012.763175. Epub 2013 Jan 28.

PMID:
23356660
44.

Neutralization of complement component C5 ameliorates the development of dextran sulfate sodium (DSS)-colitis in mice.

Aomatsu T, Imaeda H, Takahashi K, Fujimoto T, Kasumi E, Ban H, Bamba S, Yoden A, Tamai H, Fujiyama Y, Andoh A.

J Clin Biochem Nutr. 2013 Jan;52(1):72-5. doi: 10.3164/jcbn.12-63. Epub 2012 Nov 20. Erratum in: J Clin Biochem Nutr. 2013 May;52(3):255. Dosage error in published abstract; MEDLINE/PubMed abstract corrected..

45.

Polymorphisms of the Niemann-Pick C1-like 1 gene in a Japanese population.

Osaki R, Imaeda H, Takahashi K, Fujimoto T, Takeuchi T, Fujiyama Y, Andoh A.

Biomed Rep. 2013 Jan;1(1):156-160. Epub 2012 Oct 17.

46.

Magnifying endoscopy with narrow-band imaging in the differential diagnosis of gastric adenoma and carcinoma and identification of a simple indicator.

Mochizuki Y, Saito Y, Kobori A, Ban H, Ishida M, Fujiyama Y, Andoh A.

J Gastrointestin Liver Dis. 2012 Dec;21(4):383-90.

47.

CD8(+) mycosis fungoides with esophageal involvement: A case report.

Ishida M, Mochizuki Y, Saito Y, Fujiyama Y, Hodohara K, Yoshida T, Okabe H.

Oncol Lett. 2013 Jan;5(1):73-75. Epub 2012 Oct 16.

48.

Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease.

Fujimoto T, Imaeda H, Takahashi K, Kasumi E, Bamba S, Fujiyama Y, Andoh A.

J Gastroenterol Hepatol. 2013 Apr;28(4):613-9. doi: 10.1111/jgh.12073.

PMID:
23216550
49.

[Dietary therapy and nutritional therapy for inflammatory bowel disease].

Sasaki M, Fujiyama Y.

Nihon Rinsho. 2012 Feb;70 Suppl 1:354-7. Japanese. No abstract available.

PMID:
23126117
50.

[Dysbiosis in inflammatory bowel disease].

Fujiyama Y, Andoh A.

Nihon Rinsho. 2012 Feb;70 Suppl 1:79-84. Japanese. No abstract available.

PMID:
23126071

Supplemental Content

Loading ...
Support Center